ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,527, issued on May 20, was assigned to I.COM MEDICAL GMBH (Munich).

"High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease" was invented by Wolfgang Georg Konrad Muller-Lierheim (Munich) and Gysbert-Botho Van Setten (Danderyd, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention concerns a method for reducing, preventing, or delaying the onset of severe ocular surface disease, or preventing or delaying the progression of mild or moderate ocular surface disease to severe ocular surface disease, by topically administering a fluid comprising high molecular weight hyaluronic acid to the ocular...